共 50 条
- [2] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial Diabetes Therapy, 2021, 12 : 863 - 877
- [6] Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
- [7] Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis Nature Medicine, 2020, 26 : 1309 - 1309
- [10] Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (05): : 402 - 409